Isfahan University of Medical Sciences
Items where Author is "Mansour-Ghanaei, F."
Up a level |
Article
(2021) SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Lancet Infect Dis. pp. 473-481. ISSN 1473-3099 (Print) 1473-3099
(2021) The effect of spirulina on type 2 diabetes: a systematic review and meta-analysis. Journal of Diabetes and Metabolic Disorders. pp. 883-892.
(2020) The Efficacy of Vitamin D Supplementation against Nonalcoholic Fatty Liver Disease: A Meta-Analysis. J Diet Suppl. pp. 467-485. ISSN 1939-022X (Electronic) 1939-0211 (Linking)
(2020) SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial. Clinical Infectious Diseases. pp. 2206-2212. ISSN 1058-4838
(2020) The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment. Journal of Gastroenterology and Hepatology. pp. 1590-1594. ISSN 0815-9319
(2020) The effects of cranberry on cardiovascular metabolic risk factors: A systematic review and meta-analysis. Clinical Nutrition. pp. 774-788. ISSN 0261-5614
(2020) The efficacy of sour tea (Hibiscus sabdariffa L.) on selected cardiovascular disease risk factors: A systematic review and meta-analysis of randomized clinical trials. Phytotherapy Research. pp. 329-339. ISSN 0951-418X
(2019) The combination of sofosbuvir and daclatasvir is well tolerated and extremely effective in treating patients with hepatitis C with severe renal impairment including hemodialysis patinets. Journal of Hepatology. E233-E233. ISSN 0168-8278
(2019) The effects of cranberry on cardiovascular metabolic risk factors: A systematic review and meta-analysis. Clinical Nutrition. ISSN 1532-1983 (Electronic) 0261-5614 (Linking)
(2018) Molecular evolution and phylodynamics of hepatitis B virus infection circulating in Iran. Archives of Virology. pp. 1479-1488. ISSN 0304-8608
(2018) Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design. AMERICAN JOURNAL OF EPIDEMIOLOGY. pp. 647-655. ISSN 00029262 (ISSN)
(2018) SD1000: 96.4 SVR12 in 1237 patients with hepatitis C genotypes 1, 2, 3, 4 using co-formulated sofosbuvir/daclatasvir tablets manufactured in Iran - a multicenter phase 3 clinical trial including HIV co-infected, transplant, and hemodialysis patients. Journal of Viral Hepatitis. pp. 198-199. ISSN 1352-0504
(2018) Two center experience of capsule endoscopy in Iran: Report on 101 cases. F1000Research. ISSN 20461402 (ISSN)
(2016) Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income Country: A Nation-wide Study from Iran. Archives of Iranian Medicine. pp. 2-15. ISSN 1029-2977
(2015) Evolution of hepatitis B virus surface gene and protein among Iranian chronic carriers from different provinces. Iranian journal of microbiology. pp. 214-20. ISSN 2008-3289 (Print) 2008-3289 (Linking)